Bottom line
Is NCLEX a good fund? The bottom line
NCLEX is the Class I share class of Nicholas Ltd Edition Inc, an actively managed large blend mutual fund from Nicholas Ltd Edition.
It charges 0.86% — about $86 a year on every $10,000 invested, more expensive than 53% of large blend funds we track.
It returned −10.4% over one year, +1.3% a year over five years, +8.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $346 million in net assets and 62 holdings, its largest position is Cohen & Steers Inc (3.0%) and the top 10 make up 24.1% of the portfolio.
What stands out
- No front-end sales load
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What NCLEX invests in
The Fund strives to increase the value of your investment over the long-term (long-term growth).
To pursue the Funds investment objective of long-term growth, it primarily invests in common stocks of domestic corporations with small- and medium-sized market capitalizations believed to have growth potential. The Fund believes a companys annual sales volume and market capitalization (the number of shares outstanding multiplied by the per share price) are the factors most illustrative of a companys size. In distinguishing company size in terms of sales volume, the Fund considers a companys sales volume relative to peer companies in the companys industry. In terms of market capitalization, the Fund generally considers companies with market capitalizations within the range of the Russell 2000 Index as small, within the range of the Russell Midcap Index as medium, and within the range of the Standard & Poors 500 Index as large. To a lesser extent, the Fund may invest in companies with…
From the fund's prospectus (filed Jan 28, 2026).
NCLEX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| NCLEX | −10.4% | +1.3% | +8.3% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What NCLEX costs
On a $10,000 investment, NCLEX's 0.86% expense ratio costs about $86 a year. The prospectus estimates $1,061 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
NCLEX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cohen & Steers Inc CNS | 2.97% |
| 2 | Dorman Products Inc DORM | 2.84% |
| 3 | Encompass Health Corp EHC | 2.45% |
| 4 | Q2 Holdings Inc QTWO | 2.38% |
| 5 | Aptargroup Inc ATR | 2.31% |
| 6 | Bio-techne Corp TECH | 2.30% |
| 7 | La-z-boy Inc LZB | 2.24% |
| 8 | Exlservice Holdings Inc EXLS | 2.22% |
| 9 | Atricure Inc ATRC | 2.21% |
| 10 | Eplus Inc PLUS | 2.21% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 24.1% of the fund. See all top 25 holdings and asset mix →